Intellectual Property

  • February 26, 2025

    Albright Won't Rethink Tossing VolP-Pal's Patent Fights

    U.S. District Judge Alan Albright declined to reconsider the court's decision to throw out VoIP-Pal's patent lawsuits against Verizon and T-Mobile, saying Wednesday that the plaintiff has failed to offer any new evidence.

  • February 26, 2025

    Party City Approved To Sell IP, Assets For $20.6M In Ch. 11

    A Texas bankruptcy judge on Wednesday blessed retailer Party City's bid to sell its brand name and other intellectual property to an affiliate of pop culture merchandiser Ad Populum for $20.6 million, rejecting a challenge to the deal by franchise owners that claimed the buyer was ill-equipped to take on contracts with their stores.

  • February 26, 2025

    Conn. Judge Tosses False Origin Claims In Atty's Firing Suit

    A Connecticut federal judge has dismissed an attorney's lawsuit against his former firm and a litigation finance group described as its biggest client, nixing false designation and false origin claims surrounding the firm's alleged use of his name to lure clients after firing him.

  • February 26, 2025

    Liquor Cos. Clash Over Use Of 'Papi' Mark

    The owner of the trademark for Papi wine and liquor products has sued the maker of Papi's Bourbon for alleged infringement in New Jersey federal court.

  • February 26, 2025

    Texas Judge Tosses Law Firm's Claims Of Unfair Competition

    A Houston federal court has trimmed a trade secrets suit a Washington state-based immigration firm is pursuing against a Texas rival, finding two of seven claims are preempted by the Texas Uniform Trade Secrets Act.

  • February 26, 2025

    Justices Vacate TM Award That Put Co.'s Affiliates On Hook

    The U.S. Supreme Court on Wednesday vacated an award that reached nearly $47 million in a trademark dispute that questioned whether affiliates of a real estate development company should be liable for the payment even though they were not defendants in the case.

  • February 25, 2025

    Walgreens Inks $595M Deal To End COVID-19 Testing Suit

    Walgreens Boots Alliance Inc. has agreed to pay $595 million to a lab testing and diagnostics company to put to rest a dispute over COVID-19 tests, according to a Monday filing with the U.S. Securities and Exchange Commission.

  • February 25, 2025

    DC Judge Blocks Trump's Federal Funding Freeze

    A D.C. federal judge on Tuesday issued a preliminary injunction blocking the Trump administration from implementing a federal spending freeze while a group of nonprofits challenge the freeze, calling the measure "ill-conceived from the beginning."

  • February 25, 2025

    Pa. Biotech Co. Can't Escape $4M Trade Secrets Award

    A Delaware vice chancellor declined Monday to nix a nearly $4 million arbitral award issued to Finnish company UPM-Kymmene Corp. in a long-running trade secrets dispute, ruling that a link between the arbitrator and the Finnish company's counsel at DLA Piper was "at most, an attenuated connection."

  • February 25, 2025

    Netflix Show Has 'Nothing To Do With Pepperdine,' Judge Told

    Netflix and Warner Bros. Entertainment Inc. urged a California federal judge on Tuesday not to block the impending release of their new series "Running Point" amid trademark claims from Pepperdine University, saying the show has "nothing to do" with the college or its athletic teams.

  • February 25, 2025

    Sens. Reintroduce Measure To Boost Patent Injunctions

    A pair of senators moved Tuesday to reintroduce legislation that would make it easier to obtain patent injunctions, after the bill got a divided reaction at a Senate hearing when it was proposed last session.

  • February 25, 2025

    Judge Sends Koons 'Made In Heaven' IP Fight To The Afterlife

    A New York federal court on Tuesday dismissed a copyright infringement case against artist Jeff Koons, saying the dispute — featuring a snake sculpture, an Italian porn star turned parliamentarian and a messy divorce — was brought too late.

  • February 25, 2025

    9th Circ. Won't Revive Consumers' Qualcomm Antitrust Suit

    The Ninth Circuit Tuesday declined to revive cellphone buyers' antitrust suit against Qualcomm, backing a California district court's rejection of the consumers' claim that Qualcomm's policy of refusing to sell chips to cellular manufacturers that did not license its patents ran afoul of California antitrust law.

  • February 25, 2025

    Newman Says Fed. Circ. Doctors Undermine Suspension Case

    Federal Circuit Judge Pauline Newman has said the court's other judges have undermined their claims about why they suspended her, by retaining experts who questioned reports from her own doctors finding her fit to serve as a judge.

  • February 25, 2025

    HBO Escapes 'FBoy Island' Copyright Case

    A Southern District of New York judge has decided that the canceled HBO reality TV show "FBoy Island" is not "substantially similar" to a reality show pitch that was shopped around by a producer who followed up his pitch with a copyright lawsuit.

  • February 25, 2025

    5th Circ. Declines Real Estate Co.'s Injunction Bid In TM Feud

    A panel of Fifth Circuit judges has sided with a lower court's decision that Rampart Resources Inc. should not get a preliminary injunction against rival real estate company Rampart/Wurth Holding Inc.

  • February 25, 2025

    State Telecom Roundup: AI On Everyone's Minds

    It's been just over two years since artificial intelligence burst onto the scene in a big way with the launch of ChatGPT. After billions upon billions of dollars in investment, AI tools can be found everywhere from the Apple App Store to social media platforms to clothing websites.

  • February 25, 2025

    Warner Bros. Can't Nix 'ER' Ripoff Suit Over 'The Pitt'

    Warner Bros. Television can't nix a contract breach lawsuit filed by the estate of "ER" creator Michael Crichton alleging the media company's medical drama, "The Pitt," is an unauthorized reboot of "ER," after a California judge ruled the plaintiffs' evidence shows, on its face, WB's show is derived from "ER."

  • February 25, 2025

    Judge Lets RJ Reynolds, Altria Seal Docs From Juul Deal

    A federal judge in North Carolina on Tuesday granted requests by tobacco giant R.J. Reynolds Vapor Co. and rival Philip Morris' parent company to seal documents in their ongoing royalty dispute, keeping details of their licensing agreements with the vape brand JUUL confidential.

  • February 25, 2025

    J&J Says Samsung Is Breaking Deal Over Stelara Biosimilar

    Johnson & Johnson and Janssen Biotech have launched a breach of contract suit against Samsung Bioepis over their agreement to let Samsung launch a biosimilar version of J&J's blockbuster biologic Stelara before all patents expire, accusing the company of violating the provision against assigning or sublicensing the patent rights to other parties.

  • February 25, 2025

    Insulet May Face Choice: $452M Award Or Stifling Rival

    A Boston federal judge on Tuesday suggested that a medical device maker could have to choose between portions of its nine-figure trade secrets verdict it won against a rival or its request for a court order to permanently block sales of products based on the stolen technologies.

  • February 25, 2025

    Former Banner Witcoff Name Partner Dies At 99

    A retired name partner of intellectual property boutique Banner Witcoff has died at the age of 99, the firm announced Monday, saying he will be remembered as a pioneering IP attorney and a thoughtful colleague and mentor.

  • February 25, 2025

    Patent Exec Says Starbucks Is Liable For Atty's Statements

    A patent-licensing company executive pushed back on Starbucks Corp.'s attempt to exit his defamation lawsuit over statements from counsel for Starbucks, arguing the Florida federal court has jurisdiction partly because the executive lives in the district.

  • February 25, 2025

    Insurers Owe Chubb $3.3M For Safelite Defense Costs

    Two insurers must contribute $1.65 million each toward costs a Chubb unit incurred defending windshield repair company Safelite against a competitor's suit, an Ohio federal court ruled, finding the pair were not prejudiced by breaches of their policies' notice and voluntary payment provisions.

  • February 24, 2025

    Natera's $96M DNA Test Verdict Scrapped, Patents Axed

    A Delaware federal judge Monday threw out Natera's $96 million patent infringement verdict against CareDx after determining that the asserted claims in its patents related to DNA tests for organ transplant recipients are invalid.

Expert Analysis

  • Unwrapping Retailer AI Risks Amid Holiday Shopping Season

    Author Photo

    While generative artificial intelligence tools can catalyze game-changing results for retailers looking to stay ahead of the competition during the holiday season, and year-round, it can also bring certain legal risks, including product liability concerns, say attorneys at King & Spalding.

  • An Underutilized Tool To Dismiss Meritless Claims In Texas

    Author Photo

    In Texas, special appearances provide a useful but often overlooked tool for out-of-state defendants to escape meritless claims early in litigation, thus limiting discovery and creating a pathway for immediate appellate review, say attorneys at Winston & Strawn.

  • The Implications Of 2024's AI Rules And Regs For Patent Attys

    Author Photo

    Christina Huang, John Smith and Devin Stein at Faegre Drinker review this year's new rules and regulations on the development and use of artificial intelligence — from the Biden administration, the U.S. Patent and Trademark Office, the American Bar Association and various states — as they apply to patent attorneys.

  • When US Privilege Law Applies To Docs Made Outside The US

    Author Photo

    As globalization manifests itself in disputes over foreign-created documents, a California federal court’s recent trademark decision illustrates nuances of both U.S. privilege frameworks and foreign evidentiary protections that attorneys must increasingly bear in mind, say attorneys at Hunton.

  • Looking For Patterns In Pharmaceuticals' Use Of AI Patents

    Author Photo

    Merging data from the U.S. Patent and Trademark Office's artificial intelligence patent dataset and the U.S. Food and Drug Administration's Orange Book sheds light on pharmaceutical patents involving AI technology, as well as trends in the industry's use of this technology, says Kiefer Ahn at NERA.

  • Notable 2024 Trademark Cases And What To Watch In 2025

    Author Photo

    Emerging disputes between established tech giants and smaller trademark holders promise to test the boundaries of trademark protection in 2025, following a 2024 marked with disputes in areas ranging from cybersquatting to geographic marks, says Danner Kline at Bradley Arant.

  • How A 9th Circ. Identicality Ruling Could Affect AI Cos.

    Author Photo

    If the Ninth Circuit agrees to settle a district court split over whether the Digital Millennium Copyright Act requires a copy to be identical to an original to support an actionable claim for removing copyright management information, the decision could have important ramifications for artificial intelligence businesses, says Maria Sinatra at Venable.

  • The State Of USPTO Rulemaking At The End Of Vidal's Term

    Author Photo

    As U.S. Patent and Trademark Office director, Kathi Vidal placed a particular emphasis on formal rulemaking — so as she returns to private practice this week, attorneys at Irell take stock of which of her proposals made it across the finish line, and where the rest stand on the cusp of a new administration.

  • Examining Vidal's Guidance On PTAB Section 315 Time Bar

    Author Photo

    Last month's decision by outgoing U.S. Patent and Trademark Office Director Kathi Vidal in Luminex v. Signify addresses the Section 315 statutes that preclude institution of inter partes review proceedings after certain civil actions are filed, and is instructive as PTAB panels are likely to follow this approach going forward, says Amanda Wieker at McGuireWoods.

  • What A Motorcycle IP Case Says About Parallel Int'l Litigation

    Author Photo

    A Texas federal court recently rejected an electric motorcycle manufacturer's attempt to dismiss a design patent suit in the U.S. and limit the litigation to China, illustrating the challenges in trying to counter a parallel litigation strategy, say attorneys at King & Wood.

  • What 2024 Trends In Marketing, Comms Hiring Mean For 2025

    Author Photo

    The state of hiring in legal industry marketing, business development and communications over the past 12 months was marked by a number of trends — from changes in the C-suite to lateral move challenges — providing clues for what’s to come in the year ahead, says Ben Curle at Ambition.

  • Navigating The Minefield Of Patenting AI-Generated Inventions

    Author Photo

    For businesses and individuals trying to patent inventions partially developed with assistance from artificial intelligence — like software that's been coded by AI — recordkeeping and diligent documentation are of paramount importance when seeking patent protection, says Robert Plotkin at Blueshift IP.

  • How Attorneys Can Master The Art Of Eye Contact At Trial

    Author Photo

    As a growing body of research confirms that eye contact facilitates communication and influences others, attorneys should follow a few pointers to maximize the power of eye contact during voir dire, witness preparation, direct examination and cross-examination, says trial consultant Noelle Nelson.

  • Series

    Group Running Makes Me A Better Lawyer

    Author Photo

    The combination of physical fitness and community connection derived from running with a group of business leaders has, among other things, helped me to stay grounded, improve my communication skills, and develop a deeper empathy for clients and colleagues, says Jessica Shpall Rosen at Greenwald Doherty.

  • 7th Circ. Ruling Muddies Split On Trade Secret Damages

    Author Photo

    The Seventh Circuit's recent endorsement in Motorola v. Hytera of a Second Circuit limit on avoided-cost damages under the Defend Trade Secrets Act contradicts even its own precedents, and will further confuse the scope of a developing circuit conflict that the U.S. Supreme Court has already twice declined to resolve, says Jordan Rice at MoloLamken.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!